THE APEX TIMES
Berkshire Hathaway Has Owned DaVita Inc. Since 2011, Tying Warren Buffett to a Kidney-Care Bet
A Yahoo Finance roundup highlighted DaVita as one of Warren Buffett’s best long-term stock ideas, noting Berkshire Hathaway’s position in the dialysis provider dating back more than a decade.
Berkshire Hathaway has held a stake in DaVita Inc. since 2011, according to a Yahoo Finance market update published Monday. The piece framed DaVita as part of Warren Buffett’s longer-term stock thinking, a style that typically favors established businesses with durable demand rather than fast-moving themes.
DaVita, a publicly traded healthcare company listed on the New York Stock Exchange as DaVita Inc. (DVA), provides kidney care services, a sector where patients often require ongoing treatment. In general terms, that makes dialysis a recurring healthcare need, which is one of the reasons investors have historically viewed dialysis providers as businesses with steady demand profiles.
The Yahoo Finance note did not provide new disclosures about Berkshire’s stake or any changes to its size in the article. Instead, it focused on the longevity of the investment, underscoring that Berkshire has been a holder of DaVita since 2011. For market watchers, the emphasis on time is itself meaningful, since Berkshire’s approach tends to reduce the importance of near-term trading and place more weight on fundamentals that can play out over years.
Berkshire Hathaway, the Omaha-based conglomerate led by Buffett, is known for building concentrated positions in a handful of large public companies. When Berkshire buys, it often does so with the expectation of holding for a long period, provided the business continues to meet management and financial expectations. In this context, the reported 2011 start date places DaVita in the category of “held-through” investments, rather than recent portfolio experimentation.
Still, the Yahoo Finance article offered limited detail beyond the holding period. It did not specify the number of shares Berkshire owns, the current market value of the position, or whether Berkshire has trimmed or added shares during that time. It also did not disclose any company-specific performance benchmarks or financial targets that supported the original purchase or the continued ownership.
In the broader healthcare landscape, DaVita operates in a segment that can be shaped by reimbursement rules, regulatory scrutiny, and healthcare delivery economics. Those factors can influence profitability even when patient demand remains steady. For that reason, the persistence of an investor like Berkshire over a long window can announcement comfort with how the business is expected to navigate those pressures, though the Yahoo Finance post does not offer additional specifics about DaVita’s strategy or results.
Why It Matters
- A documented holding period of more than a decade reinforces how Buffett’s approach tends to emphasize durability over short-term moves.
- For investors tracking Berkshire’s portfolio, the DaVita holding helps frame which segments of healthcare the firm has been willing to underwrite for the long run.
- The dialysis-and-kidney-care theme can remain sensitive to reimbursement and regulation, so sustained ownership can be a proxy for confidence in the business’s ability to operate through policy cycles.
Sources
Key Facts
- Yahoo Finance reported that Berkshire Hathaway has held DaVita Inc. (NYSE: DVA) since 2011.
- The Yahoo Finance update associated DaVita with Warren Buffett’s long-term stock selection framework, describing it as one of his best long-term stock ideas.
- DaVita is a publicly traded healthcare company listed on the New York Stock Exchange under the ticker DVA.
- The article did not provide new information in the update about the current size of Berkshire’s DaVita stake or any changes to the position.
Finance Related
Buffett Tells Investors He’s “Never Felt Better” About Berkshire’s Future as He Prepares to Step Down as Chairman
At 96, Warren Buffett framed Berkshire Hathaway’s next chapter around continuity, disciplined succession, and the company’s long-term operating culture as he moves away from the chairman role.
Mastercard tests whether payment networks can tell humans from autonomous software
The payments giant is introducing a new “Agent Detection Score” inside its Agent Pay Trust Framework, aiming to make card networks better at distinguishing real shoppers from software agents that initiate transactions.
Dimon warns prolonged high rates could stress consumers and credit markets, raising questions for JPMorgan Chase’s outlook
JPMorgan Chase CEO Jamie Dimon cautioned that if high interest rates persist, the strain could spread from consumers to broader credit conditions. The comments underline the sensitivity of bank earnings to the path of inflation, asset prices, and credit performance, even as JPMorgan largely benefits from higher-rate environments.
Coinbase shares draw attention as Marqeta partnership scales stablecoin-backed card payments
A new collaboration between Marqeta and Coinbase aims to bring stablecoin-backed payment cards to a wider set of merchants and consumer spending rails, using Coinbase for custody, fiat conversion, and settlement on its Base network.
Mastercard launches stablecoin cards across 130 countries, tying it to a new Global Money Platform
The payments giant said it moved stablecoin card availability into 130 countries, referencing a timeline that starts at its partner BVNK’s close.
JPMorgan Chase shares sit about 8% below a record high, but the question for investors is whether the “quality” premium still holds
A market-focused piece published by The Motley Fool framed JPMorgan Chase’s recent pullback from its peak as a test of how investors value the bank’s earnings stability.
Schwab and JPMorgan say they are blocking unauthorized AI agents from executing client transactions
In a sign that “agentic” AI is moving from demos to regulated infrastructure, Charles Schwab and JPMorgan Chase both described steps to prevent software agents they do not authorize from moving money on clients’ behalf.
Visa says its stablecoin cross-border payments are moving from pilot to commercial deployment with Inyo Global
The payments network announced that its stablecoin capability is stepping up to commercial production, pointing to broader rollout beyond testing but without disclosing volumes, timelines, or regulatory approvals in the announcement.
Bank of America CEO Moynihan outlines response to major anti-money-laundering compliance failure
Speaking about a large regulatory penalty tied to money-laundering controls, Bank of America’s chief executive said the bank is focused on fixing shortcomings and strengthening compliance oversight.
Coinbase says SEC cleared exchange-traded binary options tied to its operating metrics, while also flagging long-dated Bitcoin quantum risk
The Nasdaq-listed crypto platform (COIN) disclosed that U.S. regulators have backed certain binary options that reference Coinbase-specific performance measures, even as it highlighted potential “quantum” risks that could affect Bitcoin over time.